Immune-Mediated Colitis due to Concurrent Ipilimumab and Nivolumab Therapy Treated With Infliximab.
| Autor: | Karanfilian B; Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ., Dalal I; Division of Gastroenterology & Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ., Bhurwal A; Division of Gastroenterology & Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ., Patel AV; Division of Gastroenterology & Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of therapeutics [Am J Ther] 2020 Jul/Aug; Vol. 27 (4), pp. e415-e417. |
| DOI: | 10.1097/MJT.0000000000001165 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|